IVANO BIOSCIENCE
LIVE

Serial Number

99022612

Owner

AB VALIDATION INC.

Attorney

Adelina E. Simpson

First Use Date

Jan 1, 2023

Filing Date

Jan 29, 2025

Add to watchlist:

No watchlists yet
View on USPTO

IVANO BIOSCIENCE Trademark

Serial Number: 99022612 • Registration: 8209687

IVANO BIOSCIENCE is a trademark filed by AB VALIDATION INC. on January 29, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

AB VALIDATION INC.

23-737, avenue du Château
Québec, QC G1X 3P4

Entity Type: 03

Trademark Details

Filing Date

January 29, 2025

Registration Date

April 14, 2026

First Use Anywhere

January 1, 2023

First Use in Commerce

April 1, 2024

Published for Opposition

February 24, 2026

Goods & Services

Custom design and development of chemical reagents and biochemical assays; research and development in the fields of assays, biological selection, medical screening, medical diagnostic testing, medical diagnostic imaging, and medical diagnostics using biomimicry technology; biochemical analysis; biochemical research; biomedical research services; biomedical research services, namely, preparation of biological samples for testing and analysis in research laboratories; research and development in the medical biotechnology field

Biological assays for research purposes in the fields of biological and diagnostic testing; kits comprised of biological assays and reagents for research purposes in the fields of biological and diagnostic testing; laboratory assay kits comprised of assays and reagents for research purposes; single-cell organisms for research use; Chemical diagnostic reagents for industrial use, namely, for use in biomanufacturing processes; genetically modified cells for research use; genome editing reagents for research use; viral vectors for research use; protein in raw material form for scientific and medical research; peptide substrates for scientific research purposes; diagnostic preparations in the nature of peptide substrates, other than for medical or veterinary purposes; nucleic acid sequences, other than for medical or veterinary purposes, namely, aptamers for research use; media for single-cell organism culture for research use

Medical diagnostic reagents and assays for testing of body fluids; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting autoimmune diseases; genetically modified cells for medical use, namely, diagnostic and therapeutic use; genome editing reagents for medical use, namely, diagnostic and therapeutic use; protein arrays for medical diagnosis purposes; diagnostic preparations for medical or veterinary purposes in the nature of peptide substrates; synthetic peptides for the treatment of cancer, genetic disorders, viral and infectious diseases; nucleic acid sequences for medical and veterinary purposes, namely, aptamers for diagnostic and therapeutic use; media for single-cell organism culture for medical use; single-cell organisms for medical use, namely, diagnostic and therapeutic use

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 14, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 14, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 24, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 24, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 18, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 2, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 28, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 28, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 28, 2026 ERSI
USE AMENDMENT ACCEPTED
Jan 28, 2026 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Jan 27, 2026 AUPC
USE AMENDMENT FILED
Jan 27, 2026 IUAF
TEAS AMENDMENT OF USE RECEIVED
Jan 27, 2026 EAAU
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 22, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 22, 2025 GNSL
SUSPENSION LETTER WRITTEN
Oct 22, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 21, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 21, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 21, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 21, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 21, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 9, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 30, 2025 NWOS
NEW APPLICATION ENTERED
Jan 29, 2025 NWAP
APPLICATION FILING RECEIPT MAILED
Jan 29, 2025 MAFR